PE20041077A1 - INHIBIDORES DE FACTOR Xa Y OTRAS SERINAPROTEASAS IMPLICADAS EN LA CASCADA DE LA COAGULACION - Google Patents
INHIBIDORES DE FACTOR Xa Y OTRAS SERINAPROTEASAS IMPLICADAS EN LA CASCADA DE LA COAGULACIONInfo
- Publication number
- PE20041077A1 PE20041077A1 PE2003000909A PE2003000909A PE20041077A1 PE 20041077 A1 PE20041077 A1 PE 20041077A1 PE 2003000909 A PE2003000909 A PE 2003000909A PE 2003000909 A PE2003000909 A PE 2003000909A PE 20041077 A1 PE20041077 A1 PE 20041077A1
- Authority
- PE
- Peru
- Prior art keywords
- aryl
- alkyl
- inhibitors
- factor
- chlorophenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I DONDE X1 Y X2 SON CADA UNO H, ALQUILO, ALQUENILO, ENTRE OTROS; A ES ARILO, ARILCICLOALQUILO, HETEROARILO, ENTRE OTROS; M ES ARILENO, HETEROARILENO, CICLOALQUILENO, ENTRE OTROS; Q ES ARILO, HETEROARILO, CICLOALQUILO, ENTRE OTROS, R1 ES H, ALQUILO, ARILO, ALQUENILO, HETEROARILO; R2 ES H, ALQUILO, ARILO, ENTRE OTROS; R3 ES H, ALQUILO, ARILO, HETEROARILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: (2'-METANOSULFONILBIFENIL-4-IL)AMIDA DEL ACIDO 1-[3-(4-CLOROFENIL)UREIDO]-CICLOPENTANOCARBOXILICO; (3-FLUORO-2'-SULFAMOILBIFENIL-4-IL)AMIDA DEL ACIDO 1-[3-(4-CLOROFENIL)-UREIDO]-CICLOPROPANOCARBOXILICO Y 2-[3-(4-CLOROFENIL)UREIDO]-N-(3-FLUORO-2'-METANOSULFONILBIFENIL-4-IL)-2-METIL-PROPIONAMIDA. SE REFIERE TAMBIEN A UNA FORMULACION FARMACEUTICA SIENDO INHIBIDORES DEL FACTOR Xa DE LA SERINA PROTEASA UTILES EN EL TRATAMIENTO DE TROMBOSIS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40989102P | 2002-09-11 | 2002-09-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20041077A1 true PE20041077A1 (es) | 2005-02-05 |
Family
ID=31994024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2003000909A PE20041077A1 (es) | 2002-09-11 | 2003-09-08 | INHIBIDORES DE FACTOR Xa Y OTRAS SERINAPROTEASAS IMPLICADAS EN LA CASCADA DE LA COAGULACION |
Country Status (14)
Country | Link |
---|---|
US (1) | US20040167131A1 (es) |
EP (1) | EP1539686A1 (es) |
JP (1) | JP2005538175A (es) |
AR (1) | AR041219A1 (es) |
AU (1) | AU2003260821A1 (es) |
BR (1) | BR0314219A (es) |
CA (1) | CA2497003A1 (es) |
GT (1) | GT200300192A (es) |
MX (1) | MXPA05002703A (es) |
PA (1) | PA8582001A1 (es) |
PE (1) | PE20041077A1 (es) |
TW (1) | TW200409622A (es) |
UY (1) | UY27966A1 (es) |
WO (1) | WO2004024679A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7250415B2 (en) | 2003-06-04 | 2007-07-31 | Bristol-Myers Squibb Company | 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors |
US7678913B2 (en) | 2004-12-07 | 2010-03-16 | Portola Pharmaceuticals, Inc. | Ureas as factor Xa inhibitors |
US9750757B2 (en) | 2013-10-29 | 2017-09-05 | Thomas Jefferson University | Methods of prevention or treatment for pathologic thrombosis or inflammation |
CN113233996B (zh) * | 2021-05-20 | 2022-05-20 | 河南大学 | 新型trpv1拮抗/faah抑制双靶点药物及其制备方法和应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4559157A (en) * | 1983-04-21 | 1985-12-17 | Creative Products Resource Associates, Ltd. | Cosmetic applicator useful for skin moisturizing |
LU84979A1 (fr) * | 1983-08-30 | 1985-04-24 | Oreal | Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux |
US4820508A (en) * | 1987-06-23 | 1989-04-11 | Neutrogena Corporation | Skin protective composition |
US4992478A (en) * | 1988-04-04 | 1991-02-12 | Warner-Lambert Company | Antiinflammatory skin moisturizing composition and method of preparing same |
US4938949A (en) * | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
DE4326465A1 (de) * | 1993-01-20 | 1995-02-09 | Thomae Gmbh Dr K | Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
ES2253782T3 (es) * | 1996-08-22 | 2006-06-01 | Warner-Lambert Company Llc | Antagonistas de receptor de bombesina no peptidicos. |
DE10036121A1 (de) * | 2000-07-25 | 2002-02-07 | Merck Patent Gmbh | N-Substituierte-1-amino-1,1-dialkyl-carbonsäurederivate |
DE10063008A1 (de) * | 2000-12-16 | 2002-06-20 | Merck Patent Gmbh | Carbonsäureamidderivate |
-
2003
- 2003-09-02 EP EP03795154A patent/EP1539686A1/en not_active Withdrawn
- 2003-09-02 JP JP2004535772A patent/JP2005538175A/ja active Pending
- 2003-09-02 AU AU2003260821A patent/AU2003260821A1/en not_active Abandoned
- 2003-09-02 MX MXPA05002703A patent/MXPA05002703A/es unknown
- 2003-09-02 BR BR0314219-1A patent/BR0314219A/pt not_active IP Right Cessation
- 2003-09-02 CA CA002497003A patent/CA2497003A1/en not_active Abandoned
- 2003-09-02 WO PCT/IB2003/003900 patent/WO2004024679A1/en not_active Application Discontinuation
- 2003-09-08 PE PE2003000909A patent/PE20041077A1/es not_active Application Discontinuation
- 2003-09-09 GT GT200300192A patent/GT200300192A/es unknown
- 2003-09-09 UY UY27966A patent/UY27966A1/es not_active Application Discontinuation
- 2003-09-10 AR ARP030103267A patent/AR041219A1/es unknown
- 2003-09-10 TW TW092125038A patent/TW200409622A/zh unknown
- 2003-09-11 PA PA20038582001A patent/PA8582001A1/es unknown
- 2003-09-11 US US10/662,046 patent/US20040167131A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003260821A1 (en) | 2004-04-30 |
CA2497003A1 (en) | 2004-03-25 |
PA8582001A1 (es) | 2004-03-26 |
GT200300192A (es) | 2004-05-12 |
UY27966A1 (es) | 2004-04-30 |
AR041219A1 (es) | 2005-05-11 |
MXPA05002703A (es) | 2005-05-05 |
WO2004024679A1 (en) | 2004-03-25 |
TW200409622A (en) | 2004-06-16 |
US20040167131A1 (en) | 2004-08-26 |
EP1539686A1 (en) | 2005-06-15 |
JP2005538175A (ja) | 2005-12-15 |
BR0314219A (pt) | 2005-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20020220A1 (es) | Compuestos de nitrilo de dipeptido como inhibidores de catepsina k | |
PE20070099A1 (es) | N-heteroarilpiperazinil ureas como moduladores de la amida hidrolasa del acido graso | |
PE20060438A1 (es) | Compuestos de urea como moduladores del sarcomero | |
PE20030662A1 (es) | INHIBIDORES DEL FACTOR Xa Y DE OTRAS PROTEASAS DE SERINA IMPLICADAS EN LA CASCADA DE LA COAGULACION | |
EA200600509A1 (ru) | Соединения пиримидотиофена | |
PE20081059A1 (es) | Derivados de pirimidinas como inhibidores de la actividad de la tirosina quinasa de bruton (btk) | |
AR047898A1 (es) | Benzamidas sustituidas,metodos de preparacion,composiciones farmaceuticas que las contienen y usos | |
PE20040589A1 (es) | Tiazolidinonas y su preparacion como medicamentos | |
HRP20050119A2 (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
PE20090641A1 (es) | Amidas heterociclicas | |
EA200600527A1 (ru) | Активирующее ppar соединение и содержащая его фармацевтическая композиция | |
RU2420522C2 (ru) | Новый класс ингибиторов гистондеацетилаз | |
PE20090837A1 (es) | Nuevos compuestos quimicos | |
HUP0401431A2 (hu) | Cisztein proteáz inhibitorok 2-ciano-4-amino-pirimidin szerkezettel és katepszin K inhibitor hatással, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
ATE411288T1 (de) | Aryl-, aryloxy- und alkyloxysubstituierte 1h- indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1) | |
PE20070712A1 (es) | Sulfonamidas biciclicas como moduladores del receptor de glucocorticoides en el tratamiento de enfermedades inflamatorias | |
PE20061117A1 (es) | DERIVADOS DE FENILGLICINAMIDA COMO INHIBIDORES DEL FACTOR VIIa | |
PE20070359A1 (es) | Inhibidores de pirimidinilpirazol de aurora quinasas | |
DK0719253T3 (da) | 3-amino-5-carboxy-substituerede piperidiner og 3-amino-4-carboxy-substituerede pyrrolidiner som tachykininantagonister | |
PE20030925A1 (es) | Esteres hidroxamato de acido n-(4-fenil-sustituido)-antranilico | |
HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
PE20051160A1 (es) | DERIVADOS DE BETA-AMINOACIDOS COMO INHIBIDORES DEL FACTOR Xa | |
PE20040531A1 (es) | Derivados de isoindolona, proceso de preparacion, compuestos intermedios de este proceso y composiciones farmaceuticas que los contienen | |
PE20061141A1 (es) | Imidazoles sustituidos con heterociclilamida | |
PE20141190A1 (es) | Isoxazolinas como agentes terapeuticos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |